[ad_1]
Yesterday, US media reported that 6 people had died during trials of a Corona virus vaccine developed by the US pharmaceutical company “Pfizer” and the German company “BioNTech.”
The American Politico website reported the US Food and Drug Administration report, which read: “One of the participants in the vaccine trials suffered from obesity and atherosclerosis, and died three days after taking the first dose of the drug “, explaining that” the second deceased volunteer had a heart attack after 60 days from the second dose. “
The report also noted that “of the participants who received the vaccine, two died as a result of a heart attack and a stroke, while the cause of death of two other people is being determined,” noting that “of the six who died, three they are over 55 years old ”.
Russian immunologist and drug development, research and registration expert Nikolai Kryuchkov compared the disadvantages and advantages of the Russian “Sputnik V” vaccine and the US-German “Pfizer” vaccine against the Corona virus.
Kryuchkov compared the two vaccines according to the following criteria: quality, clinical characteristics of the vaccine, ease and availability in production, standard specifications, storage, transportation and price, in addition to taking into account the “market power” of the developed company. , including the owner’s reputation, resources and contacts that determine their capabilities in the national and international market, according to the local newspaper “Komsomolskaya Pravda”.
According to the expert, the Pfizer vaccine is currently the winner of the above criteria in the world. The manufacturer has partners in different countries of the world, has extensive experience in large-scale production of complex drugs and financial capabilities. Pfizer is also easy to manufacture, and the vaccine is launched under the sponsorship of the United States government.
Source: Sputnik
[ad_2]
